Navigation Links
New Drug Combination is Able to Eradicate Breast Metastases in Mice
Date:12/17/2007

SAN ANTONIO, Dec. 17 /PRNewswire/ -- A novel combination of drugs was able to completely eradicate human breast metastases growing in mice, and shows promise for the effective treatment of patients with advanced metastatic breast cancer. Dr. Sophia Ran from Southern Illinois University School of Medicine presented the results of a study using nab-paclitaxel and bevacizumab to treat lymphatic and pulmonary metastases in female SCID mice.

Paclitaxel is a widely used cancer chemotherapy drug, originally derived from an extract of the yew tree. It can have severe side effects, some of which are related to the fact that it will not dissolve in water and has to be dissolved in organic solvents for injection. Nab-paclitaxel is a nanoparticle form of paclitaxel that is coated with a nonreactive protein, albumin, allowing it to be dissolved in water. This has reduced the side effects of the treatment, and also makes it more effective.

Bevacizumab is a monoclonal antibody against vascular endothelial growth factor A (VEGF-A), a protein that is involved in building new blood vessels. Tumors require new networks of blood vessels in order to grow.

The idea for this research came from the observation that, nf cells that survive treatment with chemotherapy, the stress of the treatment causes excess VEGF-A to be produced. The VEGF-A protects the cells against future chemotherapy, and also generates new blood vessels. Both mechanisms may contribute to tumor recurrence and metastatic spread following chemotherapy. This is the molecular basis for combining bevacizumab with nab-paclitaxel for the treatment of metastatic tumors.

For this study, human breast cancer cells were implanted into mammary fat pads (the mouse equivalent of breast tissue) of female mice. The implanted cells grew into tumors, and lymphatic and pulmonary metastases developed by the time that the drugs were administered.

The drug combination completely eradicated the origina
'/>"/>

SOURCE San Antonio Breast Cancer Symposium
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
5. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
7. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
8. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
9. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
10. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
11. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , TAINAN, Taiwan, Nov. 19 /PRNewswir...f active pharmaceutical ingredients (APIs), announ...nt Compound Safety Certification from,SafeBridge(R...noPharm,s,competency and proficiency in the safe h...s (APIs), and applies to specific laboratories and...
(Date:11/19/2009)..., , CAMBRIDGE, Mass., Nov. 19 /PRNewswire/...small molecule microarray technology to find drugs...it has raised $1M in seed financing led by incTANK...plete its initial discovery campaign that will scr...ith this investment, incTANK Ventures General Part...
(Date:11/19/2009)..., , NEWPORT NEWS, Va., Nov. 19 /PRNewswire/ ...Imaging (BSGI/MBI) has been recognized and endorse...ht against breast cancer: The Society of Breast Im...Both societies published articles supporting the f...chnology for the early detection of breast cancer....
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3MindBodyGreen to Help People Get Started with Better Healthier Greener Living by Launching Weekly 26quot 3BQ 26amp 3B A 26quot 3B Interviews and N 56764 1MindBodyGreen to Help People Get Started with Better Healthier Greener Living by Launching Weekly 26quot 3BQ 26amp 3B A 26quot 3B Interviews and N 56764 2Video 3A Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer 28TM 29 PSAs Designed to Educate Cancer Patients About the Importance Of Loweri 56762 1Video 3A Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer 28TM 29 PSAs Designed to Educate Cancer Patients About the Importance Of Loweri 56762 2Video 3A Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer 28TM 29 PSAs Designed to Educate Cancer Patients About the Importance Of Loweri 56762 3Silicon Valley Firms Partner to Promote Brain and Body Awareness 56760 1Silicon Valley Firms Partner to Promote Brain and Body Awareness 56760 2Silicon Valley Firms Partner to Promote Brain and Body Awareness 56760 3
...rbara Ann Karmanos,Cancer Institute in Detroit tod... armed targeted T cells may improve the overall su...Logo:, http://www.newscom.com/cgi-bin/prnh/20071...4, Phase I immunotherapy in women with metastatic ... anti-CD-3 x anti-Her2/neu,bispecific antibody, wa...
...ation with Other Targeted Therapies and as Mo..., - First Phase II data investigating the dual in... small molecule tyrosine-kinase inhibitors (TYKERB...ine HER2 (ErbB2) positive ...TYKERB and AVASTIN(R) (bevacizumab), a, monoclonal...
Other Medicine Technology:Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients 2Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients 3New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 2New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 3New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 4New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 5New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 6New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 7New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 8New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 9New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 10
(Date:11/22/2009)...te blood vessel growth has now been found to be re...nt of polyps that characterize one of the most sev...esearchers suggests. The finding gives scientists ...at this form of the disease, which typically resis...a constant irritation and swelling of the nasal pa...
(Date:11/22/2009)...rld Famous Lasik surgeon, Dr. Gulani continues to ...pursuit for vision beyond 20/20.,Known as the Doct...l and is widely published in teaching LASIK surgeo...e, FL (PRWEB) November 22, 2009 -- Dr. Arun C. Gul... by Goldline Research as one of the leading Laser ...
(Date:11/22/2009)...cells to attack recipient,s tissue, study finds, ...Researchers are reporting that a genetic variation... who,s had a bone-marrow transplant will develop a..., The immune system-related complication occurs ... and the donor does not. , When that,s the cas...
(Date:11/22/2009)...n & Machine post You Tube video demonstrating ... Landover, MD (PRWEB) Nove...d in learning what a really rugged waterproof keyb... Cool Keyboard vs Washable Competitors Keyboard HD... how the premium, Really Cool Keyboard from Man &...
(Date:11/21/2009)...rovides for an unprecedented expansion of federall... is not for preserving and protecting human life? ... Charmaine Yoest ,, WASHINGTON, Nov. 21 /PRNe...tion President and CEO Dr. Charmaine Yoest respond...e following statement: ,, "This was a pro-abor...
Breaking Medicine News(10 mins):Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 3Health News:Dr. Arun Gulani Listed in Forbes Magazine as One of The Leading Laser Eye Surgeons of the United States 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2
...ed as part of company,s, comprehensive Pressure Ul... preventing pressure ulcers, ...,announced today an advanced line of therapeutic p...ble, painful pressure,ulcers in their facilities. ...
...ccommodating Lens Designed to ..., June 30 Bausch & Lomb announced,today that it h...stration,(FDA) to market the Crystalens HD(TM) in ...eration of the only FDA,approved accommodating len...
...ernational, Inc. (OTC Bulletin Board: MDFI), a com...ecords management solutions, today announced,the l...Initiative") created,to impact the quality of heal...t decisions. Moreover, through the COP,Initiative,...
...ersity of Pennsylvania School of Medicine and coll...oteins called zinc fingers to engineer T cells to ...ers and colleagues from Sangamo Biosciences (Nasda...the goal of using modified T cells from an HIV-inf...
...ance -, LEXINGTON, Mass., June 30th Instrumentat...ceived the prestigious Supplier,Performance Award ...The,award recognizes outstanding performance in qu... Breakthrough,Conference and Exhibition in Nashvil...
...de On-Demand Channel, TALLAHASSEE, Fla., June 30 ...f the YouCare video contest. Rachel Sbrissa from,C...video that shares why,she chooses not to smoke. Sb...dly lost the battle a few weeks ago., Donna Aftuc...
Other Medicine News:Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 2Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 3Health News:Crystalens HD(TM) Receives FDA Approval 2Health News:MedeFile Launches 'COP Initiative' to Provide Nation's Law Enforcement Agencies With Funding for Policing Technologies 2Health News:MedeFile Launches 'COP Initiative' to Provide Nation's Law Enforcement Agencies With Funding for Policing Technologies 3Health News:MedeFile Launches 'COP Initiative' to Provide Nation's Law Enforcement Agencies With Funding for Policing Technologies 4Health News:MedeFile Launches 'COP Initiative' to Provide Nation's Law Enforcement Agencies With Funding for Policing Technologies 5Health News:Zinc finger proteins put personalized HIV therapy within reach 2Health News:Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year 2Health News:Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest 2
deJuan Micro Pic Forceps - Black
Madlab Biopsy Forceps
Kaplan Subretinal Forceps
Lambert Membrane Pick-Peeling Forceps
Medicine Products: